Literature DB >> 31439008

Quality of life among Sudanese patients with multiple sclerosis in Khartoum state using (MSQoL-54) questionnaire.

Etedal Ahmed Abu Elbasher Ibrahim1,2, Alsadig Gassoum3,4, Israa El Imam IshagAgib3.   

Abstract

OBJECTIVE: To assess the quality of life, physical and mental factors, determine association between age, education status, disease duration and MSQOL-54 physical and Mental Health Composite scores among Sudanese patients with multiple sclerosis. This cross-section study was conducted among 32 MS patients at the National center for Neurological Science, Khartoum from January 2017 to June 2018. Using Multiple sclerosis Quality of life (MSQoL-54) questionnaire.
RESULTS: Thirty two MS patients were participated in this study, 30 (94%) were females and 2 (6%) were males, 25 (78.1%) were found in age group < 40 years overall score of MSQoL-54 was 66.4 ± 21.9, Physical Health Composite (PHC) was 71.6 ± 21.3 and Mental Health Composite (MHC) was 61.2 ± 22.4. This study indicated that, non-graduated, advanced age and longer disease duration was significantly associated with poor Physical Health Composite and Mental Health Composite.

Entities:  

Keywords:  MSQOL-54; Multiple Sclerosis; Quality of life; Sudan

Mesh:

Year:  2019        PMID: 31439008      PMCID: PMC6704515          DOI: 10.1186/s13104-019-4565-9

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

Multiple sclerosis is a demyelinating disease and the most common immune-mediated disorder affecting the central nervous system [1]. The disease is common among young usually female of child bearing age in white population, temperate climate region and high socio-economic community and thought to be rare in North African countries like Sudan. The disease is a common cause of disability among our population, so measurement of Quality of life, both health and mental composite are vital for the medical care, rehabilitation and nursing. Furthermore this is the first study to determine the QoL in MS Sudanese patients. Several studies have identically shown, that patients with multiple sclerosis experience lower Quality of life compared to healthy control group [2]. Fatigue is the most common symptom [2]. In addition to the chronic nature of the disease, lack of prognosis and definitive therapy, cause several psychological symptoms among which depression, anxiety and stress are the most common [3]. Specific symptoms include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease progress [4].

Main text

Methods

This descriptive cross-section study was conducted from January 2017 to June 2018. Thirty two (32) patients aged 18+ years were diagnosed with multiple sclerosis clinically and radiologically according to modified Macdonald criteria were recruited and investigated by using Multiple sclerosis Quality of life MSQoL-54 questionnaire. The sub scales are: physical function, role limitations-physical, role limitations-emotional, pain, emotional well-being, energy, health perceptions, social function, cognitive function, health distress, overall quality of life, and sexual function. Other neurological diseases, serious cardiovascular, orthopedic or other disability were excluded from the study. Data were analyzed by the Statistical Package for Social Science (SPSS), version 21. Chi square test. P value of < 0.05 was considered to be statistically significant. Descriptive statistics was used to calculate the mean and the standard deviation of the total scores and the sub-scales of the MSQoL-54 tool. Psychometric properties the MSQoL-54 12 subscales show good internal consistency with Cronbach Alpha ranging from 0.75 to 0.96. Test–retest reliability is good with interclass correlation co-efficiency ranging from 0.66 to 0.96. There is evidence for the validity of the questionnaire. The questionnaire in this study showed associations with MS symptom severity, level of ambulation, employment limitations due to health problems and hospital admission (Additional file 1) [5]. Ethical approval was obtained from National Center for Neurological Science, Khartoum, Sudan.

Results

A total of 32 MS patients, 30 (94%) were females and 2 (6%) were males most of them 25 (78.1%) were found in age group less than 40 years. Concerning to the marital status, one-half 16 (50%) were married, 12 (37.5%) were singles, 3 (9.4%) were divorced and one patient (3.1%) was widower. Regarding to the origin, 17 (53.1%) of the patients were from north, 10 (31.3%) from east, 4 (12.5%) from west and one patients from south. Most of the patients 27 (84.4%) were university educated, 3 (9.4%) primary educated and 2 (6.3%) were secondary educated. The majority of the patients 17 (53.1%) had disease duration from 5 to 10 years, 11 (34.4%) less than 5 years and 4 (12.5%) of them had MS duration for more than 10 years. The overall score of MSQoL-54 among patients was 66.4 ± 21.9, Physical Health Composite (PHC) was 71.6 ± 21.3 and Mental Health Composite (MHC) was 61.2 ± 22.4. In comparison between the mean score of MSQoL-54 subsets (PHC and MHC) in MS patients, Descriptive statistics was used to calculate the mean and the standard deviation of the total scores and the sub-scales of the MSQoL-54 tool. Physical Health Composite (PHC) and Mental Health Composite (MHC) was significantly associated with the ages of the patients as; the younger patients (< 40 years) were significantly had highest mean score in both PHC (78.5 ± 11.5; P = 0.000) and MHC (69.6 ± 13.3; P = 0.001) than other groups (Tables 1, 2). Moreover, Physical Health Composite (PHC) and Mental Health Composite (MHC) was significantly associated with educational levels of the patients as; the university educated patients (< 40 years) were significantly had highest mean score in both PHC (82.3 ± 17.7; P = 0.000) and MHC (75.6 ± 17.7; P = 0.000) than other groups (Table 3). Similarly, Physical Health Composite (PHC) and Mental Health Composite (MHC) was significantly associated with the MS duration of the patients as; patients with duration < 5 years were significantly had highest mean score in both PHC (70.2 ± 14.1; P = 0.000) and MHC (75.3 ± 13.6; P = 0.000) than other groups (Additional file 2: Table S1).
Table 1

The mean and standard deviation of MSQoL-54 among Sudanese MS patients in Khartoum state, 2018 (N = 32)

MeanSD
Physical Health Composite (PHC)71.621.3
Mental Health Composite (MHC)61.222.4
Overall score66.421.9
Table 2

The comparison between MSQoL-54 subsets (PHC and MHC) in MS patients in Khartoum state regarding to the age (N = 32)

Age (years)Physical Health Composite (PHC)Mental Health Composite (MHC)
Mean (SD)Mean (SD)
< 4078.5 (11.5)69.6 (13.3)
40–6062.6 (17.1)57.7 (18.0)
> 6056.1 (15.7)50.1 (17.7)
P value0.000*0.001*

ANOVA test was used

* P value is significant (< 0.05)

Table 3

The comparison between MSQoL-54 subsets (PHC and MHC) in MS patients in Khartoum state regarding to the educational levels (N = 32)

Educational levelsPhysical Health Composite (PHC)Mental Health Composite (MHC)
Mean (SD)Mean (SD)
Primary66.9 (10.3)56.4 (15.0)
Secondary71.3 (16.1)63.9 (12.0)
University82.3 (17.7)75.6 (17.7)
P value0.000*0.000*

ANOVA test was used

* P value is significant (< 0.05)

The mean and standard deviation of MSQoL-54 among Sudanese MS patients in Khartoum state, 2018 (N = 32) The comparison between MSQoL-54 subsets (PHC and MHC) in MS patients in Khartoum state regarding to the age (N = 32) ANOVA test was used * P value is significant (< 0.05) The comparison between MSQoL-54 subsets (PHC and MHC) in MS patients in Khartoum state regarding to the educational levels (N = 32) ANOVA test was used * P value is significant (< 0.05)

Discussion

Our study is the first comprehensive attempt to provide an estimate of quality of life in multiple sclerosis patients. In this study, most of the patients were young less than 40 years (76.7%). And this is similar to other studies done by Berer K et al. and Lozano et al. which stated that, the age of multiple sclerosis was found to be between the ages of 15 to 45 years [1, 6]. Our study showed that, the Quality of life overall mean score was 66.4 ± 21.9, Physical Health Composite was 71.6 ± 21.3 and Mental Health Composite was 61.2 ± 22.4. This was similar to the findings reported by Algahtani et al. [7] who found that, quality of life of MS patients measured 73.87 ± 23.41 associated with significant effects on the patient’s life. On the other hand, Sara et al. [8] noticed that, males had significantly higher scores compared to females in both physical and mental domains of MSQOL-54 (P < 0.001). Furthermore, in this study, secondary graduates with age less than 40 years, with longer disease duration was significantly associated with poor Physical Health Composite and Mental Health Composite in MSQOL-54 tool subsets (P < 0.005). In addition to that, younger primary school and illiterates had poor mental MSQOL-54 (P < 0.05). Quality of life has been extensively studied in patients with multiple sclerosis [9]. Although research in this field is relatively new,the first papers appears in the literature in the early 1990s, it has been a subject of intense scientific research ever since [10]. Due to the progressive and disabling nature of the disease, Quality of life can be substantially reduced. In comparison to other studies which showed no significant relationship between QoL and the duration of disease [11]. Our research showed that, patients whom diagnosed with MS and have long disease duration had poor mental and physical health composite than patients with a shorter duration. In contrast others have found that, time since MS diagnosis have a significant effect on the mental aspect of quality of life [12] and it was differed across disease course but varied by age and duration of disease [13]. Furthermore, better quality of life score was reported in people with longer disease duration.

Conclusion

The present study concludes that, multiple sclerosis disease among Sudanese patients was considerably affected in the Quality of life. Moreover; patients with advanced age, lower than university education and had longer disease duration was significantly associated with poor Physical Health Composite and Mental Health Composite.

Limitation

The study was a cross-sectional study, so a large sample size was needed to consolidate our findings. The questionnaire needs a translation to Arabic language. Examination of the responsiveness requires longitudinal data. The questionnaire is lengthy and need about 40 min to 1 h for each patient. Additional file 1. MSQol-54 questionnaire. Additional file 2. The comparison between MSQoL-54 subsets (PHC and MHC) in MS patients in Khartoum state regarding to the MS duration (N = 32).
  12 in total

1.  Health status and quality of life of people with multiple sclerosis.

Authors:  H L Ford; E Gerry; M H Johnson; A Tennant
Journal:  Disabil Rehabil       Date:  2001-08-15       Impact factor: 3.033

2.  Depression and quality of life in multiple sclerosis.

Authors:  S Fruehwald; H Loeffler-Stastka; R Eher; B Saletu; U Baumhackl
Journal:  Acta Neurol Scand       Date:  2001-11       Impact factor: 3.209

3.  Association of factors influencing health-related quality of life in MS.

Authors:  N Pfaffenberger; K-P Pfeiffer; M Deibl; S Höfer; V Günther; H Ulmer
Journal:  Acta Neurol Scand       Date:  2006-08       Impact factor: 3.209

Review 4.  Microbial view of central nervous system autoimmunity.

Authors:  Kerstin Berer; Gurumoorthy Krishnamoorthy
Journal:  FEBS Lett       Date:  2014-04-18       Impact factor: 4.124

5.  Health-related quality of life and depression in an Italian sample of multiple sclerosis patients.

Authors:  Francesco Patti; Manuela Cacopardo; Filippo Palermo; Maria Rita Ciancio; Rossella Lopes; Domenico Restivo; Arturo Reggio
Journal:  J Neurol Sci       Date:  2003-07-15       Impact factor: 3.181

6.  Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis.

Authors:  R A Rudick; D Miller; J D Clough; L A Gragg; R G Farmer
Journal:  Arch Neurol       Date:  1992-12

7.  Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.

Authors:  Ghasem Salehpoor; Sajjad Rezaei; Mozaffar Hosseininezhad
Journal:  Iran J Nurs Midwifery Res       Date:  2014-11

8.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

9.  Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge.

Authors:  Karine Baumstarck; Laurent Boyer; Mohamed Boucekine; Pierre Michel; Jean Pelletier; Pascal Auquier
Journal:  Mult Scler Int       Date:  2013-02-28

10.  Quality of life among multiple sclerosis patients in Saudi Arabia.

Authors:  Hussein A Algahtani; Bader H Shirah; Faris A Alzahrani; Hind A Abobaker; Nebras A Alghanaim; Juan S Manlangit
Journal:  Neurosciences (Riyadh)       Date:  2017-10       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.